SENO CJC-1295 + Ipamorelin Lyophilized Powder Bulk Wholesale Price

Description

Dual-Pathway GH/IGF-1 Research Peptide for Endocrine & Metabolic Studies

SENO CJC-1295 + Ipamorelin is a high-purity combination research peptide supplied as lyophilized powder for advanced laboratory investigations involving growth hormone signaling, endocrine regulation, receptor-mediated pathways, and metabolic research models.

This peptide formulation combines:

• CJC-1295 — a GHRH (Growth Hormone Releasing Hormone) analog
• Ipamorelin — a selective growth hormone secretagogue

The dual-mechanism design enables synergistic investigation of GH/IGF-1 axis modulation and receptor signaling interactions in controlled laboratory environments.

Available specification:

• CP10 — 10mg × 10 vials

Each batch is manufactured using automated solid-phase peptide synthesis (SPPS), followed by analytical verification using HPLC and mass spectrometry to support purity, structural integrity, and batch reproducibility.

This product is supplied exclusively for laboratory research applications.

What Is CJC-1295 + Ipamorelin?

CJC-1295 + Ipamorelin is a combination peptide formulation developed for research involving growth hormone regulatory pathways.

CJC-1295 Component

CJC-1295 is a synthetic GHRH analog investigated for its interaction with growth hormone releasing hormone receptors and downstream endocrine signaling mechanisms.

Research involving CJC-1295 commonly focuses on:

• GH secretion signaling
• pituitary receptor activation
• endocrine pathway modulation
• IGF-1 regulatory studies

Ipamorelin Component

Ipamorelin is a selective growth hormone secretagogue studied for its interaction with ghrelin-related receptor pathways and growth hormone release signaling.

Laboratory investigations may involve:

• receptor-binding studies
• secretagogue pathway analysis
• endocrine signaling dynamics
• peptide-receptor interaction models

Combined together, the peptide blend allows researchers to study synergistic activation of GH/IGF-1-related signaling systems using complementary receptor mechanisms.

The formulation is supplied as a white to off-white lyophilized powder for enhanced stability during storage and transport.

Research Applications

CJC-1295 + Ipamorelin is commonly utilized in laboratory investigations involving:

• GH/IGF-1 axis research
• endocrine signaling studies
• receptor-mediated peptide interactions
• growth hormone release pathway analysis
• metabolic signaling investigations
• peptide synergy research
• receptor pharmacology
• cellular signaling experiments
• preclinical metabolic models
• biochemical pathway investigations

Its dual-pathway mechanism makes it useful in studies involving coordinated endocrine and receptor-signaling systems.

Molecular Formula

CJC-1295

C152H252N44O42C_{152}H_{252}N_{44}O_{42}C152​H252​N44​O42​

Ipamorelin

C38H49N9O5C_{38}H_{49}N_9O_5C38​H49​N9​O5​

Molecular Weight

Approximate combined peptide molecular profile:

$\sim 4.5kDa$

CAS Number

Product Specifications

Mechanism of Action

The CJC-1295 + Ipamorelin combination is studied for complementary activation of growth hormone-related signaling pathways.

CJC-1295 Pathway Activity

CJC-1295 is investigated as a GHRH receptor agonist that may influence:

• pituitary signaling pathways
• growth hormone secretion dynamics
• endocrine communication
• IGF-1 pathway modulation

Ipamorelin Pathway Activity

Ipamorelin is researched for selective interaction with ghrelin-related receptor systems involved in:

• growth hormone release signaling
• peptide-receptor interaction
• endocrine pathway activation
• metabolic signaling responses

The combined peptide system allows researchers to investigate coordinated endocrine signaling using dual receptor-mediated mechanisms.

Solubility

CJC-1295 + Ipamorelin is generally soluble in:

• sterile water
• bacteriostatic water
• phosphate-buffered saline (PBS)
• selected laboratory buffers

Suggested laboratory preparation volume:

$2-3mLper10mgvial$

Actual preparation concentration should be optimized according to individual experimental protocols and assay requirements.

Storage Recommendations

For optimal peptide stability:

• Store lyophilized peptide at -20°C
• Protect from moisture and direct light
• Avoid repeated temperature fluctuations
• Maintain sterile handling conditions

After reconstitution:

• Aliquot into sterile containers when possible
• Store at 2–8°C or according to laboratory protocol
• Minimize freeze-thaw cycles
• Use prepared solutions promptly

Stability Information

The lyophilized formulation helps preserve structural integrity and reduce degradation risk during storage and transport.

Peptide stability may be affected by:

• hydrolysis
• oxidation
• microbial contamination
• repeated freeze-thaw cycles
• temperature exposure
• prolonged storage after reconstitution

Controlled storage conditions support reproducible experimental performance and peptide integrity.

Research Studies & Scientific Interest

CJC-1295 + Ipamorelin is widely investigated in endocrine and receptor-signaling research due to its complementary pathway activity.

Research areas commonly include:

• GH/IGF-1 signaling mechanisms
• endocrine regulation models
• peptide synergy investigations
• receptor-binding studies
• growth hormone pathway analysis
• metabolic signaling research
• cellular communication pathways
• preclinical endocrine studies

The dual-mechanism design provides researchers with a model for studying coordinated hormonal signaling interactions.

Manufacturing & Quality Assurance

SENO manufactures CJC-1295 + Ipamorelin using automated solid-phase peptide synthesis (SPPS) under controlled laboratory conditions.

Production workflow includes:

• pharmaceutical-grade amino acid sourcing
• automated peptide sequence assembly
• controlled coupling and deprotection cycles
• preparative HPLC purification
• mass spectrometry verification
• sterile lyophilization procedures

Each batch undergoes analytical verification to support:

• purity consistency
• molecular identity
• structural integrity
• sequence fidelity
• batch reproducibility

This manufacturing process helps ensure reliable performance in sensitive endocrine and receptor-signaling research applications.

COA (Certificate of Analysis)

Analytical documentation may include:

• batch identification
• HPLC purity profile
• molecular verification
• appearance inspection
• manufacturing date
• storage recommendations
• quality-control approval

COA documentation supports laboratory traceability and internal quality assurance workflows.

HPLC & Mass Spectrometry Verification

Each batch undergoes analytical testing using:

• High-Performance Liquid Chromatography (HPLC)
• Mass Spectrometry (MS)

These analytical methods help verify:

• peptide purity
• molecular identity
• structural consistency
• impurity assessment
• batch reproducibility

Analytical chromatograms and molecular verification data may be available for laboratory documentation purposes.

Reconstitution Guide

Recommended Laboratory Procedure

1. Allow vial to reach room temperature before opening.
2. Select sterile solvent appropriate for the research protocol.
3. Slowly add solvent along the vial wall.
4. Gently swirl until fully dissolved.
5. Avoid vigorous shaking or foaming.
6. Aliquot into sterile containers if needed.
7. Store prepared solutions according to laboratory requirements.

Researchers should optimize preparation concentrations according to specific experimental designs.

Handling Precautions

• For laboratory research use only
• Not intended for human or veterinary administration
• Use laboratory PPE during handling
• Maintain aseptic preparation conditions
• Avoid repeated freeze-thaw cycles
• Dispose of materials according to institutional biosafety regulations

Shipping Information

• Worldwide FedEx or equivalent courier shipping
• Lyophilized peptide supplied for improved transport stability
• Ambient temperature shipping with protective packaging
• Packaging designed to maintain vial integrity during international transport

Frequently Asked Questions (FAQ)

What is CJC-1295 + Ipamorelin used for in research?

This peptide combination is commonly studied in GH/IGF-1 axis research, endocrine signaling investigations, receptor pharmacology, and metabolic pathway studies.

Why combine CJC-1295 and Ipamorelin?

The two peptides act through complementary receptor systems, allowing researchers to investigate synergistic endocrine signaling and coordinated growth hormone pathway activation.

Why is the peptide supplied in lyophilized form?

Lyophilization helps improve peptide stability by reducing moisture-related degradation during storage and transportation.

What analytical methods are used for quality verification?

Each batch is verified using HPLC and mass spectrometry to confirm purity, molecular identity, and structural consistency.

How should the peptide be stored?

Lyophilized peptide should generally be stored at -20°C. Reconstituted solutions should be handled carefully and protected from repeated freeze-thaw exposure.

Is this product intended for therapeutic or medical use?

No. SENO CJC-1295 + Ipamorelin is supplied strictly for laboratory research applications only and is not approved for human or veterinary administration.